Mammographic fibroglandular density, right breast
ICD-10 R92.321 is a billable code used to indicate a diagnosis of mammographic fibroglandular density, right breast.
Mammographic fibroglandular density refers to the composition of breast tissue as seen on a mammogram, where dense fibroglandular tissue appears white on the imaging, potentially obscuring lesions. This finding is significant as it can affect the sensitivity of mammography in detecting breast cancer. Women with higher fibroglandular density may have a higher risk of breast cancer, making it crucial for clinicians to monitor these patients closely. The density is categorized into four levels, with R92.321 specifically indicating a high level of density in the right breast. This code is used when the mammogram report notes this finding, which may not be associated with any symptoms but is an important factor in breast cancer screening and risk assessment.
Documentation should include the patient's breast density assessment, any associated risk factors, and recommendations for follow-up imaging or screening.
Patients presenting for routine screening mammograms who are found to have high fibroglandular density.
Consideration of family history and personal risk factors for breast cancer is essential for accurate coding.
Acute care documentation should detail any acute breast symptoms, imaging results, and follow-up plans.
Patients presenting with breast pain or lumps who have a history of high fibroglandular density.
Emergency settings may require expedited imaging and documentation of findings for immediate care.
Used when a patient undergoes a mammogram that reveals fibroglandular density.
Mammography report must clearly indicate findings of density.
Radiology must ensure accurate reporting of density levels.
R92.321 indicates a high level of fibroglandular density in the right breast as seen on a mammogram, which can affect cancer screening.
